MedTrace Logo

Investigation of Milk Peptides (Pep2Dia®) on Postprandial Blood Glucose Profile in Prediabetic Subjects

NCT04375449 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2022-05-11

No results posted yet for this study

Summary

The goal is to investigate the 180 min postprandial response on blood glucose and insulin levels after intake of Pep2Dia® in two different dosages compared to placebo in the context of a meal challenge test, providing 75 g of carbohydrates. Pep2Dia® will be administered 15 min prior to a standardized challenge meal.

Conditions

  • Prediabetic State

Interventions

DIETARY_SUPPLEMENT

Pep2dia

what is the effect of Pep2dia on postprandial glycemia after a meal rich in carbohydrates (75g)

DIETARY_SUPPLEMENT

maltodextrin

maltodextrin

Sponsors & Collaborators

  • BioTeSys GmbH

    collaborator OTHER

  • Ingredia S.A.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
25 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-05-04
Primary Completion
2020-07-25
Completion
2020-12-15

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04375449 on ClinicalTrials.gov